(19)
(11) EP 1 044 267 A2

(12)

(88) Date of publication A3:
10.09.1999

(43) Date of publication:
18.10.2000 Bulletin 2000/42

(21) Application number: 98966103.8

(22) Date of filing: 28.12.1998
(51) International Patent Classification (IPC)7C12N 15/12, C12N 15/62, C12N 5/10, C12N 1/21, C12N 1/19, C07K 14/705, C07K 16/28, A61K 38/17, A61K 39/395, G01N 33/53, G01N 33/68
(86) International application number:
PCT/US9827/688
(87) International publication number:
WO 9933/967 (08.07.1999 Gazette 1999/27)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 29.12.1997 US 68925 P

(71) Applicant: REGENERON PHARMACEUTICALS, INC.
Tarrytown, NY 10591-6707 (US)

(72) Inventor:
  • VALENZUELA, David, M.
    Yorktown Heights, NY 10598 (US)

(74) Representative: Goldin, Douglas Michael et al
J.A. KEMP & CO.14 South SquareGray's Inn
London WC1R 5LX
London WC1R 5LX (GB)

   


(54) NOVEL NUCLEIC ACID AND POLYPEPTIDE WITH HOMOLOGY TO THE TNF-RECEPTORS